Accustem Sciences Inc. is a clinical stage diagnostics company developing genomic tests for oncology decision-making. Its two lead products are MSC, a 24-miRNA blood-based assay for classifying lung nodules as benign or malignant, and StemPrintER, a 20-gene prognostic assay predicting distant recurrence risk in ER+/HER2- breast cancer patients. The company targets a combined US market opportunity exceeding $6.3 billion annually and plans to expand into ancillary hereditary and somatic mutation testing.
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-04-03 | 2024-12-31 | 0001641172-25-002594 | EDGAR | 56K words |
| 2024-03-22 | 2023-12-31 | 0001493152-24-010938 | EDGAR | 55K words |
| 2023-02-15 | 2022-12-31 | 0001493152-23-005208 | EDGAR | 49K words |
| 2022-04-18 | 2021-12-31 | 0001493152-22-010172 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001493152-26-038323 | EDGAR | 14K words |
| 2025-11-12 | 2025-09-30 | 0001493152-25-021919 | EDGAR | 14K words |
| 2025-08-14 | 2025-06-30 | 0001641172-25-023786 | EDGAR | 14K words |
| 2025-05-20 | 2025-03-31 | 0001641172-25-011721 | EDGAR | 13K words |
| 2024-11-18 | 2024-09-30 | 0001493152-24-046438 | EDGAR | 13K words |
| 2024-09-16 | 2024-06-30 | 0001493152-24-036330 | EDGAR | 13K words |
| 2024-05-20 | 2024-03-31 | 0001493152-24-020584 | EDGAR | 12K words |
| 2023-11-13 | 2023-09-30 | 0001493152-23-040286 | EDGAR | 14K words |
| 2023-08-14 | 2023-06-30 | 0001493152-23-028164 | EDGAR | 13K words |
| 2023-05-05 | 2023-03-31 | 0001493152-23-015555 | EDGAR | 12K words |
| 2022-11-08 | 2022-09-30 | 0001493152-22-030905 | EDGAR | 14K words |
| 2022-08-12 | 2022-06-30 | 0001493152-22-022218 | EDGAR | 14K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-11-26 | 0001493152-25-025156 | EDGAR | 1K words |
| 2024-12-30 | 0001493152-24-052550 | EDGAR | 1K words |
| 2024-04-10 | 0001493152-24-014171 | EDGAR | 1K words |
| 2023-06-09 | 0001493152-23-020727 | EDGAR | 0K words |
| 2023-06-07 | 0001493152-23-020328 | EDGAR | 0K words |
| 2022-11-16 | 0001493152-22-032628 | EDGAR | 1K words |
| 2022-10-14 | 0001493152-22-028454 | EDGAR | 1K words |
| 2022-06-21 | 0001493152-22-017353 | EDGAR | — |
| 2022-04-05 | 0001493152-22-009142 | EDGAR | — |
| 2022-03-10 | 0001493152-22-006524 | EDGAR | — |
33 total filings indexed. 7 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001850767 |
| Ticker | ACUT |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ACUT (~200 tokens, structured JSON with cryptographic provenance)